James A Schoeneck
CIK 1420987 · Interim President · last filed 2025-08-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.9K
Companies
5
Total Filings
73
Lifetime Open-Market Net
-$1.79M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLDI | Director | 84,167 | $0.15 | $12.9K | $150.0K | 2 | 2025-08-25 |
| KYNTRA BIO, INC. (FGEN) Delisted | Director | 68,432 | $9.75 | $667.2K | -$1.20M | 28 | 2025-07-02 |
| Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted | Director | 2,035,668 | $0.01 | $11.8K | $0 | 6 | 2024-10-15 |
| ANAB | Director | — | $56.07 | — | $0 | 2 | 2018-02-06 |
| Assertio Therapeutics, Inc (DEPO) Delisted | President and CEO | 495,105 | — | — | -$743.6K | 35 | 2017-02-10 |
Recent Filings · Page 2 of 8
73 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-04-22 | Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted | Grant (A) | +375,000 | $150.0K | EDGAR |
| 2024-01-04 | Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted | Grant (A) | +10,625 | $19.1K | EDGAR |
| 2023-08-14 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | KYNTRA BIO, INC. (FGEN) Delisted | Mixed | +1,189 | -$128.0K | EDGAR |
| 2022-06-21 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | +15,777 | $0 | EDGAR |
| 2021-05-28 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | +4,700 | $0 | EDGAR |
| 2021-01-06 | KYNTRA BIO, INC. (FGEN) Delisted | Exer (M) | +6,000 | $58.6K | EDGAR |
| 2020-08-21 | KYNTRA BIO, INC. (FGEN) Delisted | Exer (M) | +6,000 | $35.7K | EDGAR |
| 2020-06-08 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | +4,700 | $0 | EDGAR |
| 2020-01-08 | KYNTRA BIO, INC. (FGEN) Delisted | Tax (F) | −10,928 | -$473.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.